dnaJ Peptide for Relieving Rheumatoid Arthritis - Related Studies

dnaJ Peptide for Relieving Rheumatoid Arthritis

This study has been completed.

Study NCT00000435. Last updated on July 30, 2007. Information provided by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Rheumatoid Arthritis

2	Additional conditions recognized in this trial
		Arthritis
		Arthritis, Rheumatoid

3	More general conditions related to this trial
		Autoimmune Diseases
		Connective Tissue Diseases
		Immune System Diseases
		Joint Diseases
		Musculoskeletal Diseases
		Rheumatic Diseases

4	Interventions listed in this trial
		dnaJ peptide
		None-placebo

5	Sponsors listed in this trial
		National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)